Integrating anatomy and biology for a better pancreatic cancer prognosis

Treatment of pancreatic ductal adenocarcinoma (PDAC) is extremely difficult due to its aggressive nature and limited diagnostic tools. While traditional staging systems, such as the TNM classification, focus on physical factors, they fall short of providing a comprehensive prognosis. The Tianjin grading system addresses this gap by integrating physical, biological, and patient status factors. Source…

Read More

Next-gen CAR-T cell therapy shows early promise in patients with refractory B-cell acute lymphoblastic leukemia

Safety and efficacy data from a Phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational next-generation CD19-directed CAR-T cell therapy produced in 48 hours using the T-CHARGE platform, shows a manageable safety profile and antitumor activity. The best overall response, defined as complete remission with complete remission or incomplete recovery of blood counts, was between…

Read More